Loading company
Drugs Made In America Acquisition Corp.
DMAA · Nasdaq · ·
$10.85+0.1%Sep 28 close
- 1M
- +0.9%
- 6M
- +3.5%
- 1Y
- +5.6%
DMAA · Nasdaq · ·
$10.85+0.1%Sep 28 close
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Profit | $1.7M | $2.3M | -24.54% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Drugs Made In America Acquisition Corp. has no earnings call transcript available.